Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1982-05-14
1983-07-26
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
043954049
ABSTRACT:
Novel peptides representing fragments of thymosin .beta..sub.3 and .beta..sub.4 have been synthesized and are active agents affecting regulation, differentiation and function of thymus dependent lymphocytes and macrophages.
REFERENCES:
patent: 4261886 (1981-04-01), Goldstein et al.
Goldstein Allan L.
Low Teresa L. K.
George Washington University
Gould George M.
Phillips Delbert R.
Saxe Jon S.
Shearer Peter R.
LandOfFree
Synthetic thymosin .beta..sub.3 and .beta..sub.4 analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic thymosin .beta..sub.3 and .beta..sub.4 analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic thymosin .beta..sub.3 and .beta..sub.4 analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2221721